Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
Status:
Recruiting
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
To compare the efficacy of two different dosage regimens of intravenous immune globulin
(IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia, and to
reduce related adverse reactions and economic burdens on the premise of ensuring the
remission rate
Phase:
Phase 4
Details
Lead Sponsor:
Fujian Medical University Union Hospital
Collaborators:
Longyan City First Hospital Nanping First Hospital Affiliated to Fujian Medical University Quanzhou First Hospital Affiliated to Fujian Medical University The Affiliated Hospital Of Guizhou Medical University The Affiliated Hospital of Putian University The First Affiliated Hospital of Xiamen University The Second Hospital of Anhui Medical University Zhangzhou Affiliated Hospital of Fujian Medical University